Practical Advice on the Management of Tumor Lysis Syndrome
Closing out his discussion on tumor lysis syndrome, Anthony Perissinotti, PharmD, BCOP, shares practical advice on its identification and management.
Tumor Lysis Syndrome: Treatment Armamentarium
Guideline-directed treatment strategies available to patients with identified tumor lysis syndrome.
Tumor Lysis Syndrome: Prophylactic Strategies
An overview of the prophylactic strategies that may be utilized to reduce the likelihood of tumor lysis syndrome.
Role of a Pharmacist in Managing Tumor Lysis Syndrome
Expert perspective on the role of a pharmacist in managing patients with identified tumor lysis syndrome.
An Overview on Tumor Lysis Syndrome in Cancer Care
Anthony Perissinotti, PharmD, BCOP, highlights associated risk for tumor lysis syndrome and identifies signs and symptoms.
Further Understanding of Immune Mechanisms in Tumor Microenvironment Is Key to Advancing Immunotherapy in Solid Tumors
Navigating Systemic Therapy for RCC: Balancing Risk Status and Response
ADCs, Novel Targets Represent Next Wave of Treatment Advances in mCRPC
Precision Medicine in Prostate Cancer Care: Keeping Up With Evolving Guidance for Testing and Decision Making
2 Clarke Drive Cranbury, NJ 08512